Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4788762
Max Phase: Preclinical
Molecular Formula: C47H58N10O8
Molecular Weight: 891.04
Molecule Type: Unknown
Associated Items:
ID: ALA4788762
Max Phase: Preclinical
Molecular Formula: C47H58N10O8
Molecular Weight: 891.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc2ccccc2c1)NC(=O)[C@@H](N)CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C47H58N10O8/c1-2-35(42(51)60)53-45(63)38(22-27-15-18-32(58)19-16-27)56-44(62)37(13-7-8-20-48)54-47(65)40(24-31-26-52-36-12-6-5-11-33(31)36)57-46(64)39(55-43(61)34(49)25-41(50)59)23-28-14-17-29-9-3-4-10-30(29)21-28/h3-6,9-12,14-19,21,26,34-35,37-40,52,58H,2,7-8,13,20,22-25,48-49H2,1H3,(H2,50,59)(H2,51,60)(H,53,63)(H,54,65)(H,55,61)(H,56,62)(H,57,64)/t34-,35?,37-,38-,39?,40-/m0/s1
Standard InChI Key: SMCOYWUQASMHQE-CIXHJIQDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 891.04 | Molecular Weight (Monoisotopic): 890.4439 | AlogP: 0.71 | #Rotatable Bonds: 24 |
Polar Surface Area: 319.74 | Molecular Species: BASE | HBA: 10 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.42 | CX Basic pKa: 10.27 | CX LogP: -0.22 | CX LogD: -2.01 |
Aromatic Rings: 5 | Heavy Atoms: 65 | QED Weighted: 0.04 | Np Likeness Score: 0.16 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):